

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit assembly (GO:0000028) | 4.67733192 |
| 2 | DNA deamination (GO:0045006) | 4.47609481 |
| 3 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.09240119 |
| 4 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.09240119 |
| 5 | modulation by symbiont of host immune response (GO:0052553) | 4.09240119 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 4.09240119 |
| 7 | modulation by symbiont of host defense response (GO:0052031) | 4.09240119 |
| 8 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.09240119 |
| 9 | regulation of telomere maintenance via telomerase (GO:0032210) | 3.96524428 |
| 10 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.79143032 |
| 11 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.77325216 |
| 12 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.76738994 |
| 13 | neutrophil activation involved in immune response (GO:0002283) | 3.71534307 |
| 14 | protein localization to kinetochore (GO:0034501) | 3.66454423 |
| 15 | respiratory burst (GO:0045730) | 3.63335931 |
| 16 | DNA strand elongation (GO:0022616) | 3.62357579 |
| 17 | ribosomal large subunit biogenesis (GO:0042273) | 3.58517742 |
| 18 | response to peptidoglycan (GO:0032494) | 3.57002805 |
| 19 | immunoglobulin mediated immune response (GO:0016064) | 3.54641896 |
| 20 | viral transcription (GO:0019083) | 3.49732153 |
| 21 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.44175163 |
| 22 | protein localization to chromosome, centromeric region (GO:0071459) | 3.43706416 |
| 23 | telomere maintenance via recombination (GO:0000722) | 3.41598540 |
| 24 | translational termination (GO:0006415) | 3.38134842 |
| 25 | maturation of SSU-rRNA (GO:0030490) | 3.37835715 |
| 26 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.36553475 |
| 27 | negative regulation of cell killing (GO:0031342) | 3.36553475 |
| 28 | DNA replication initiation (GO:0006270) | 3.36222549 |
| 29 | maturation of 5.8S rRNA (GO:0000460) | 3.30388827 |
| 30 | mitotic sister chromatid segregation (GO:0000070) | 3.30198388 |
| 31 | NIK/NF-kappaB signaling (GO:0038061) | 3.28469921 |
| 32 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.26514378 |
| 33 | ribosomal small subunit biogenesis (GO:0042274) | 3.25536489 |
| 34 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.24542011 |
| 35 | mitotic recombination (GO:0006312) | 3.24300873 |
| 36 | negative regulation of gene silencing (GO:0060969) | 3.17254014 |
| 37 | kinetochore organization (GO:0051383) | 3.16130330 |
| 38 | translational elongation (GO:0006414) | 3.15718510 |
| 39 | negative regulation of B cell apoptotic process (GO:0002903) | 3.15259999 |
| 40 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.12099911 |
| 41 | regulation of mast cell degranulation (GO:0043304) | 3.11326471 |
| 42 | mitotic metaphase plate congression (GO:0007080) | 3.09425541 |
| 43 | histone H2A acetylation (GO:0043968) | 3.09183657 |
| 44 | DNA unwinding involved in DNA replication (GO:0006268) | 3.08502304 |
| 45 | telomere maintenance via telomere lengthening (GO:0010833) | 3.03926612 |
| 46 | CENP-A containing nucleosome assembly (GO:0034080) | 3.03620640 |
| 47 | negative regulation of interleukin-12 production (GO:0032695) | 3.02966840 |
| 48 | metaphase plate congression (GO:0051310) | 2.99427848 |
| 49 | protein localization to chromosome (GO:0034502) | 2.98393281 |
| 50 | regulation of RIG-I signaling pathway (GO:0039535) | 2.98150371 |
| 51 | kinetochore assembly (GO:0051382) | 2.95902521 |
| 52 | establishment of chromosome localization (GO:0051303) | 2.95470750 |
| 53 | meiotic chromosome segregation (GO:0045132) | 2.95140184 |
| 54 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.92431129 |
| 55 | chromatin remodeling at centromere (GO:0031055) | 2.92172496 |
| 56 | mitotic nuclear envelope disassembly (GO:0007077) | 2.90910153 |
| 57 | sister chromatid segregation (GO:0000819) | 2.90710106 |
| 58 | spindle assembly checkpoint (GO:0071173) | 2.87856640 |
| 59 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.87330638 |
| 60 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.87330638 |
| 61 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 2.87158828 |
| 62 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 2.87158828 |
| 63 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 2.87158828 |
| 64 | negative regulation of sister chromatid segregation (GO:0033046) | 2.87158828 |
| 65 | detection of bacterium (GO:0016045) | 2.86779647 |
| 66 | negative regulation of chromosome segregation (GO:0051985) | 2.86484664 |
| 67 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.86241832 |
| 68 | formation of translation preinitiation complex (GO:0001731) | 2.85637138 |
| 69 | mitotic spindle assembly checkpoint (GO:0007094) | 2.85523324 |
| 70 | metallo-sulfur cluster assembly (GO:0031163) | 2.83869011 |
| 71 | iron-sulfur cluster assembly (GO:0016226) | 2.83869011 |
| 72 | regulation of superoxide anion generation (GO:0032928) | 2.83824086 |
| 73 | regulation of gamma-delta T cell activation (GO:0046643) | 2.83122160 |
| 74 | translational initiation (GO:0006413) | 2.82758157 |
| 75 | pentose metabolic process (GO:0019321) | 2.82050517 |
| 76 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.81804742 |
| 77 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.81627151 |
| 78 | mitotic chromosome condensation (GO:0007076) | 2.81066289 |
| 79 | regulation of spindle organization (GO:0090224) | 2.80260422 |
| 80 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.79844702 |
| 81 | rRNA modification (GO:0000154) | 2.79528911 |
| 82 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.79443296 |
| 83 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 2.79093530 |
| 84 | regulation of mitochondrial translation (GO:0070129) | 2.78426931 |
| 85 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.77346049 |
| 86 | response to host immune response (GO:0052572) | 2.77346049 |
| 87 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.76821220 |
| 88 | positive regulation of B cell differentiation (GO:0045579) | 2.76736648 |
| 89 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 2.76473916 |
| 90 | detection of other organism (GO:0098543) | 2.76011425 |
| 91 | UV protection (GO:0009650) | 2.75400030 |
| 92 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.75122466 |
| 93 | protein insertion into membrane (GO:0051205) | 2.74690908 |
| 94 | response to muramyl dipeptide (GO:0032495) | 2.73200965 |
| 95 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.72909438 |
| 96 | leukocyte aggregation (GO:0070486) | 2.72729201 |
| 97 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.71807003 |
| 98 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.70295409 |
| 99 | negative regulation of RNA splicing (GO:0033119) | 2.69568276 |
| 100 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.68856057 |
| 101 | cellular protein complex disassembly (GO:0043624) | 2.68643098 |
| 102 | B cell mediated immunity (GO:0019724) | 2.68015378 |
| 103 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.67831247 |
| 104 | DNA replication-independent nucleosome organization (GO:0034724) | 2.67831247 |
| 105 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.66457201 |
| 106 | snRNA metabolic process (GO:0016073) | 2.65909253 |
| 107 | attachment of spindle microtubules to kinetochore (GO:0008608) | 2.65874754 |
| 108 | rRNA processing (GO:0006364) | 2.65814242 |
| 109 | viral mRNA export from host cell nucleus (GO:0046784) | 2.65270180 |
| 110 | spindle checkpoint (GO:0031577) | 2.64455503 |
| 111 | viral life cycle (GO:0019058) | 2.64424885 |
| 112 | cotranslational protein targeting to membrane (GO:0006613) | 2.64393013 |
| 113 | regulation of chromatin silencing (GO:0031935) | 2.63743853 |
| 114 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.62842220 |
| 115 | regulation of chromosome segregation (GO:0051983) | 2.62812321 |
| 116 | macrophage activation involved in immune response (GO:0002281) | 2.62803986 |
| 117 | snRNA processing (GO:0016180) | 2.62281558 |
| 118 | DNA replication checkpoint (GO:0000076) | 2.62093373 |
| 119 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.61315023 |
| 120 | telomere organization (GO:0032200) | 2.61199026 |
| 121 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.61103201 |
| 122 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.61103201 |
| 123 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.61065252 |
| 124 | telomere maintenance (GO:0000723) | 2.60893004 |
| 125 | pentose-phosphate shunt (GO:0006098) | 2.60764478 |
| 126 | protein targeting to ER (GO:0045047) | 2.59979109 |
| 127 | regulation of leukocyte degranulation (GO:0043300) | 2.59740766 |
| 128 | rRNA metabolic process (GO:0016072) | 2.58629728 |
| 129 | negative regulation of phagocytosis (GO:0050765) | 2.58063638 |
| 130 | histone arginine methylation (GO:0034969) | 2.57570461 |
| 131 | nucleobase biosynthetic process (GO:0046112) | 2.57201312 |
| 132 | nuclear envelope disassembly (GO:0051081) | 2.57184925 |
| 133 | membrane disassembly (GO:0030397) | 2.57184925 |
| 134 | mannose metabolic process (GO:0006013) | 2.56519995 |
| 135 | mitotic spindle checkpoint (GO:0071174) | 2.56073202 |
| 136 | mismatch repair (GO:0006298) | 2.54892549 |
| 137 | ncRNA 3-end processing (GO:0043628) | 2.54777971 |
| 138 | protein complex disassembly (GO:0043241) | 2.54636140 |
| 139 | regulation of B cell apoptotic process (GO:0002902) | 2.54037216 |
| 140 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 2.54027263 |
| 141 | modulation by virus of host process (GO:0019054) | 2.53230290 |
| 142 | pyrimidine-containing compound salvage (GO:0008655) | 2.52552128 |
| 143 | pyrimidine nucleoside salvage (GO:0043097) | 2.52552128 |
| 144 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.52465535 |
| 145 | ribosome biogenesis (GO:0042254) | 2.52046930 |
| 146 | mitochondrial fusion (GO:0008053) | 2.51910185 |
| 147 | regulation of mitotic sister chromatid segregation (GO:0033047) | 2.51835901 |
| 148 | regulation of sister chromatid segregation (GO:0033045) | 2.51835901 |
| 149 | regulation of mitotic sister chromatid separation (GO:0010965) | 2.51835901 |
| 150 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.51189707 |
| 151 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.50393512 |
| 152 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.50320760 |
| 153 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.49975444 |
| 154 | granulocyte differentiation (GO:0030851) | 2.49399272 |
| 155 | oxidative phosphorylation (GO:0006119) | 2.49343801 |
| 156 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.49188873 |
| 157 | GDP-mannose metabolic process (GO:0019673) | 2.48120876 |
| 158 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.48055218 |
| 159 | leukocyte degranulation (GO:0043299) | 2.47779387 |
| 160 | amino sugar catabolic process (GO:0046348) | 2.46736690 |
| 161 | positive regulation of release of cytochrome c from mitochondria (GO:0090200) | 2.46702871 |
| 162 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 2.46523729 |
| 163 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 2.46269669 |
| 164 | reactive oxygen species biosynthetic process (GO:1903409) | 2.45974566 |
| 165 | positive regulation of gene expression, epigenetic (GO:0045815) | 2.45835396 |
| 166 | protein localization to endoplasmic reticulum (GO:0070972) | 2.45590613 |
| 167 | myeloid cell activation involved in immune response (GO:0002275) | 2.45492045 |
| 168 | regulation of B cell differentiation (GO:0045577) | 2.45450276 |
| 169 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.45163779 |
| 170 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.42538844 |
| 171 | deoxyribonucleotide catabolic process (GO:0009264) | 2.40302232 |
| 172 | NADPH regeneration (GO:0006740) | 2.39760274 |
| 173 | negative regulation of innate immune response (GO:0045824) | 2.38323980 |
| 174 | heme biosynthetic process (GO:0006783) | 2.34908800 |
| 175 | neutrophil activation (GO:0042119) | 2.34573694 |
| 176 | mitochondrion transport along microtubule (GO:0047497) | 2.34252911 |
| 177 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.34252911 |
| 178 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.33547639 |
| 179 | response to host (GO:0075136) | 2.33547639 |
| 180 | response to host defenses (GO:0052200) | 2.33547639 |
| 181 | defense response to protozoan (GO:0042832) | 2.33533334 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.45376589 |
| 2 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 4.33751418 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.34196386 |
| 4 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.17457400 |
| 5 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.17411675 |
| 6 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 3.05012644 |
| 7 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.70265035 |
| 8 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.49983508 |
| 9 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.49684588 |
| 10 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.43942935 |
| 11 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.42534419 |
| 12 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.40264736 |
| 13 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.38820307 |
| 14 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.38633268 |
| 15 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.33912489 |
| 16 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.31793780 |
| 17 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.27508562 |
| 18 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.27002736 |
| 19 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.20499043 |
| 20 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.18878521 |
| 21 | MYC_22102868_ChIP-Seq_BL_Human | 2.15567921 |
| 22 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.13893986 |
| 23 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.07540433 |
| 24 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.05691242 |
| 25 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.03559225 |
| 26 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.02986785 |
| 27 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.98919835 |
| 28 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.98490017 |
| 29 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.98308594 |
| 30 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.94881463 |
| 31 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.94289678 |
| 32 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.84022553 |
| 33 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.82929900 |
| 34 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.80343287 |
| 35 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.78982399 |
| 36 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.78478758 |
| 37 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.77214899 |
| 38 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.74048640 |
| 39 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.70952642 |
| 40 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.70404035 |
| 41 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.67085603 |
| 42 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.66168110 |
| 43 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.64635189 |
| 44 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.64462266 |
| 45 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.63708084 |
| 46 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63275496 |
| 47 | P68_20966046_ChIP-Seq_HELA_Human | 1.63234148 |
| 48 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.62395120 |
| 49 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.59903839 |
| 50 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.59857120 |
| 51 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.59821134 |
| 52 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.59256636 |
| 53 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.58765370 |
| 54 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.57693346 |
| 55 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.55496477 |
| 56 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.55387113 |
| 57 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.54367805 |
| 58 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.54251045 |
| 59 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.52988485 |
| 60 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.51032488 |
| 61 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.50447374 |
| 62 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.50383461 |
| 63 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.49415391 |
| 64 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.49155600 |
| 65 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.48508007 |
| 66 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.44593008 |
| 67 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.44104533 |
| 68 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.44086440 |
| 69 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.42265665 |
| 70 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.41386219 |
| 71 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.41355942 |
| 72 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.40803965 |
| 73 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.39713989 |
| 74 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.39104952 |
| 75 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.36237584 |
| 76 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.35497232 |
| 77 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.34399102 |
| 78 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.34364285 |
| 79 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.34136064 |
| 80 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.33246004 |
| 81 | MYB_26560356_Chip-Seq_TH2_Human | 1.32510548 |
| 82 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.29936211 |
| 83 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.28897596 |
| 84 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.28274664 |
| 85 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.27726817 |
| 86 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.27400462 |
| 87 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.27255171 |
| 88 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.24986268 |
| 89 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.24603662 |
| 90 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.24322241 |
| 91 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.24127936 |
| 92 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.23762563 |
| 93 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.23474709 |
| 94 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.23128915 |
| 95 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.22820185 |
| 96 | * MYB_26560356_Chip-Seq_TH1_Human | 1.21789857 |
| 97 | * MAF_26560356_Chip-Seq_TH1_Human | 1.21650783 |
| 98 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.18268737 |
| 99 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.17987990 |
| 100 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.17914475 |
| 101 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.17512088 |
| 102 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.16891148 |
| 103 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.15802470 |
| 104 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14956801 |
| 105 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.14847527 |
| 106 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.14697515 |
| 107 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.14688630 |
| 108 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.14376396 |
| 109 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.14270716 |
| 110 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13968614 |
| 111 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.13589196 |
| 112 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12558123 |
| 113 | * SA1_27219007_Chip-Seq_Bcells_Human | 1.11821607 |
| 114 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.10519811 |
| 115 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.10439078 |
| 116 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.09161346 |
| 117 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.08813445 |
| 118 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.08642004 |
| 119 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.08495745 |
| 120 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.06980510 |
| 121 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.04504747 |
| 122 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.04161865 |
| 123 | * MAF_26560356_Chip-Seq_TH2_Human | 1.03468907 |
| 124 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.03468518 |
| 125 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01753115 |
| 126 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.00797561 |
| 127 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.96871779 |
| 128 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.95342933 |
| 129 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.93639758 |
| 130 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.93306363 |
| 131 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.91769433 |
| 132 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.88878218 |
| 133 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.88741797 |
| 134 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.87818457 |
| 135 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.87490414 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 3.77782661 |
| 2 | MP0003111_abnormal_nucleus_morphology | 3.74089552 |
| 3 | MP0002396_abnormal_hematopoietic_system | 3.71851027 |
| 4 | MP0010094_abnormal_chromosome_stability | 3.24831598 |
| 5 | MP0003077_abnormal_cell_cycle | 3.05993756 |
| 6 | MP0008058_abnormal_DNA_repair | 3.05310705 |
| 7 | MP0005058_abnormal_lysosome_morphology | 3.01763767 |
| 8 | MP0001835_abnormal_antigen_presentation | 2.91952551 |
| 9 | MP0008057_abnormal_DNA_replication | 2.70807171 |
| 10 | MP0000685_abnormal_immune_system | 2.59507360 |
| 11 | MP0004957_abnormal_blastocyst_morpholog | 2.52455340 |
| 12 | MP0005671_abnormal_response_to | 2.36657921 |
| 13 | MP0003763_abnormal_thymus_physiology | 2.35691657 |
| 14 | MP0003303_peritoneal_inflammation | 2.35357829 |
| 15 | MP0005397_hematopoietic_system_phenotyp | 2.34163675 |
| 16 | MP0001545_abnormal_hematopoietic_system | 2.34163675 |
| 17 | MP0008007_abnormal_cellular_replicative | 2.27779630 |
| 18 | MP0001800_abnormal_humoral_immune | 2.12807247 |
| 19 | MP0009278_abnormal_bone_marrow | 2.12744513 |
| 20 | MP0002398_abnormal_bone_marrow | 2.08277411 |
| 21 | MP0004147_increased_porphyrin_level | 2.05434492 |
| 22 | MP0005451_abnormal_body_composition | 2.02720913 |
| 23 | MP0000465_gastrointestinal_hemorrhage | 1.89111551 |
| 24 | MP0009785_altered_susceptibility_to | 1.85432975 |
| 25 | MP0001873_stomach_inflammation | 1.85276710 |
| 26 | MP0000689_abnormal_spleen_morphology | 1.84483173 |
| 27 | MP0002452_abnormal_antigen_presenting | 1.83937046 |
| 28 | MP0002420_abnormal_adaptive_immunity | 1.82823651 |
| 29 | MP0003172_abnormal_lysosome_physiology | 1.82729982 |
| 30 | MP0003786_premature_aging | 1.82008163 |
| 31 | MP0002722_abnormal_immune_system | 1.80986290 |
| 32 | MP0001819_abnormal_immune_cell | 1.80663564 |
| 33 | MP0004808_abnormal_hematopoietic_stem | 1.80523449 |
| 34 | MP0000490_abnormal_crypts_of | 1.79606382 |
| 35 | MP0003436_decreased_susceptibility_to | 1.79373368 |
| 36 | MP0002723_abnormal_immune_serum | 1.79185239 |
| 37 | MP0000716_abnormal_immune_system | 1.73563321 |
| 38 | MP0009333_abnormal_splenocyte_physiolog | 1.72599268 |
| 39 | MP0005025_abnormal_response_to | 1.72566975 |
| 40 | MP0000703_abnormal_thymus_morphology | 1.68361189 |
| 41 | MP0006035_abnormal_mitochondrial_morpho | 1.65697567 |
| 42 | MP0005000_abnormal_immune_tolerance | 1.64157090 |
| 43 | MP0002429_abnormal_blood_cell | 1.62250288 |
| 44 | MP0000015_abnormal_ear_pigmentation | 1.61553630 |
| 45 | MP0009840_abnormal_foam_cell | 1.60735749 |
| 46 | MP0009379_abnormal_foot_pigmentation | 1.60631277 |
| 47 | MP0010352_gastrointestinal_tract_polyps | 1.60140281 |
| 48 | MP0006292_abnormal_olfactory_placode | 1.59901644 |
| 49 | MP0002132_abnormal_respiratory_system | 1.59600239 |
| 50 | MP0005387_immune_system_phenotype | 1.55831349 |
| 51 | MP0001790_abnormal_immune_system | 1.55831349 |
| 52 | MP0006036_abnormal_mitochondrial_physio | 1.55584522 |
| 53 | MP0005464_abnormal_platelet_physiology | 1.50561827 |
| 54 | MP0006082_CNS_inflammation | 1.49974075 |
| 55 | MP0002095_abnormal_skin_pigmentation | 1.49385871 |
| 56 | MP0002019_abnormal_tumor_incidence | 1.48887291 |
| 57 | MP0001853_heart_inflammation | 1.45558285 |
| 58 | MP0005075_abnormal_melanosome_morpholog | 1.45067990 |
| 59 | MP0002419_abnormal_innate_immunity | 1.41657847 |
| 60 | MP0008877_abnormal_DNA_methylation | 1.40335479 |
| 61 | MP0002653_abnormal_ependyma_morphology | 1.35762828 |
| 62 | MP0008995_early_reproductive_senescence | 1.34122210 |
| 63 | MP0000350_abnormal_cell_proliferation | 1.30758477 |
| 64 | MP0005174_abnormal_tail_pigmentation | 1.30324348 |
| 65 | MP0000313_abnormal_cell_death | 1.28348406 |
| 66 | MP0002405_respiratory_system_inflammati | 1.27964292 |
| 67 | MP0001730_embryonic_growth_arrest | 1.26362769 |
| 68 | MP0001533_abnormal_skeleton_physiology | 1.25829922 |
| 69 | MP0002148_abnormal_hypersensitivity_rea | 1.25747628 |
| 70 | MP0010155_abnormal_intestine_physiology | 1.22089738 |
| 71 | MP0002166_altered_tumor_susceptibility | 1.20357754 |
| 72 | MP0008932_abnormal_embryonic_tissue | 1.17570582 |
| 73 | MP0003191_abnormal_cellular_cholesterol | 1.11748303 |
| 74 | MP0003787_abnormal_imprinting | 1.09447519 |
| 75 | MP0001845_abnormal_inflammatory_respons | 1.08702163 |
| 76 | MP0003866_abnormal_defecation | 1.08532735 |
| 77 | MP0009764_decreased_sensitivity_to | 1.08214752 |
| 78 | MP0002006_tumorigenesis | 1.07401216 |
| 79 | MP0003806_abnormal_nucleotide_metabolis | 1.06645978 |
| 80 | MP0003724_increased_susceptibility_to | 1.06498507 |
| 81 | MP0000343_altered_response_to | 1.04456284 |
| 82 | MP0005083_abnormal_biliary_tract | 1.03564850 |
| 83 | MP0000858_altered_metastatic_potential | 1.02427135 |
| 84 | MP0002210_abnormal_sex_determination | 1.01814818 |
| 85 | MP0004381_abnormal_hair_follicle | 1.00077053 |
| 86 | MP0003136_yellow_coat_color | 0.97989828 |
| 87 | MP0000371_diluted_coat_color | 0.96164442 |
| 88 | MP0003656_abnormal_erythrocyte_physiolo | 0.95569020 |
| 89 | MP0000358_abnormal_cell_content/ | 0.94846061 |
| 90 | MP0001849_ear_inflammation | 0.94749532 |
| 91 | MP0001929_abnormal_gametogenesis | 0.92286403 |
| 92 | MP0000604_amyloidosis | 0.91911843 |
| 93 | MP0000678_abnormal_parathyroid_gland | 0.89811881 |
| 94 | MP0001986_abnormal_taste_sensitivity | 0.87855664 |
| 95 | MP0010307_abnormal_tumor_latency | 0.87104049 |
| 96 | MP0004185_abnormal_adipocyte_glucose | 0.86092999 |
| 97 | MP0001764_abnormal_homeostasis | 0.84830884 |
| 98 | MP0002080_prenatal_lethality | 0.84787532 |
| 99 | MP0003646_muscle_fatigue | 0.84778350 |
| 100 | MP0001145_abnormal_male_reproductive | 0.83991569 |
| 101 | MP0008469_abnormal_protein_level | 0.81437415 |
| 102 | MP0002160_abnormal_reproductive_system | 0.80536879 |
| 103 | MP0003123_paternal_imprinting | 0.80470806 |
| 104 | MP0008260_abnormal_autophagy | 0.80137639 |
| 105 | MP0005380_embryogenesis_phenotype | 0.79310485 |
| 106 | MP0001672_abnormal_embryogenesis/_devel | 0.79310485 |
| 107 | MP0003329_amyloid_beta_deposits | 0.77523543 |
| 108 | MP0005310_abnormal_salivary_gland | 0.76079445 |
| 109 | MP0002254_reproductive_system_inflammat | 0.74147017 |
| 110 | MP0004858_abnormal_nervous_system | 0.73105705 |
| 111 | MP0002075_abnormal_coat/hair_pigmentati | 0.72897858 |
| 112 | MP0004947_skin_inflammation | 0.72034763 |
| 113 | MP0003075_altered_response_to | 0.71770832 |
| 114 | MP0003984_embryonic_growth_retardation | 0.69983456 |
| 115 | MP0005410_abnormal_fertilization | 0.69730767 |
| 116 | MP0000747_muscle_weakness | 0.69709760 |
| 117 | MP0001697_abnormal_embryo_size | 0.68913041 |
| 118 | MP0005394_taste/olfaction_phenotype | 0.68878715 |
| 119 | MP0005499_abnormal_olfactory_system | 0.68878715 |
| 120 | MP0001661_extended_life_span | 0.68577388 |
| 121 | MP0000653_abnormal_sex_gland | 0.68142493 |
| 122 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.67088276 |
| 123 | MP0001663_abnormal_digestive_system | 0.65910188 |
| 124 | MP0002088_abnormal_embryonic_growth/wei | 0.65746556 |
| 125 | MP0001119_abnormal_female_reproductive | 0.64600575 |
| 126 | MP0002086_abnormal_extraembryonic_tissu | 0.64312985 |
| 127 | MP0005389_reproductive_system_phenotype | 0.63890293 |
| 128 | MP0001188_hyperpigmentation | 0.62819725 |
| 129 | MP0003300_gastrointestinal_ulcer | 0.62434890 |
| 130 | MP0000477_abnormal_intestine_morphology | 0.60399440 |
| 131 | MP0005377_hearing/vestibular/ear_phenot | 0.60392511 |
| 132 | MP0003878_abnormal_ear_physiology | 0.60392511 |
| 133 | MP0003186_abnormal_redox_activity | 0.58210223 |
| 134 | MP0003718_maternal_effect | 0.57016871 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Aplastic anemia (HP:0001915) | 3.94371359 |
| 2 | Abnormality of macrophages (HP:0004311) | 3.94276422 |
| 3 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.88425330 |
| 4 | Abnormal number of erythroid precursors (HP:0012131) | 3.88287557 |
| 5 | Colon cancer (HP:0003003) | 3.77383112 |
| 6 | Reticulocytopenia (HP:0001896) | 3.69984371 |
| 7 | Thrombocytosis (HP:0001894) | 3.46382040 |
| 8 | Myositis (HP:0100614) | 3.38539387 |
| 9 | Entropion (HP:0000621) | 3.37165564 |
| 10 | Abnormality of reticulocytes (HP:0004312) | 3.31652093 |
| 11 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.28107670 |
| 12 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.15125667 |
| 13 | Chromsome breakage (HP:0040012) | 3.13830169 |
| 14 | Chronic otitis media (HP:0000389) | 3.12361594 |
| 15 | Panhypogammaglobulinemia (HP:0003139) | 3.12277805 |
| 16 | Hypertensive crisis (HP:0100735) | 3.10437794 |
| 17 | Reticulocytosis (HP:0001923) | 3.08755726 |
| 18 | Increased cerebral lipofuscin (HP:0011813) | 3.03649364 |
| 19 | IgM deficiency (HP:0002850) | 3.01806477 |
| 20 | Microvesicular hepatic steatosis (HP:0001414) | 2.93874132 |
| 21 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.83638496 |
| 22 | Increased serum ferritin (HP:0003281) | 2.80411729 |
| 23 | Recurrent viral infections (HP:0004429) | 2.79619261 |
| 24 | Recurrent abscess formation (HP:0002722) | 2.77659000 |
| 25 | Medulloblastoma (HP:0002885) | 2.76334051 |
| 26 | Petechiae (HP:0000967) | 2.75100725 |
| 27 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.72642017 |
| 28 | Recurrent bronchitis (HP:0002837) | 2.71143279 |
| 29 | Cerebellar dysplasia (HP:0007033) | 2.66219624 |
| 30 | Myelodysplasia (HP:0002863) | 2.65066140 |
| 31 | Ragged-red muscle fibers (HP:0003200) | 2.64701694 |
| 32 | Birth length less than 3rd percentile (HP:0003561) | 2.61815827 |
| 33 | Nasal polyposis (HP:0100582) | 2.61349507 |
| 34 | Abnormal gallbladder physiology (HP:0012438) | 2.54932953 |
| 35 | Cholecystitis (HP:0001082) | 2.54932953 |
| 36 | Recurrent fungal infections (HP:0002841) | 2.53473635 |
| 37 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.52678793 |
| 38 | Stomatitis (HP:0010280) | 2.51731520 |
| 39 | Type I transferrin isoform profile (HP:0003642) | 2.50513591 |
| 40 | Abnormality of B cell number (HP:0010975) | 2.50241587 |
| 41 | B lymphocytopenia (HP:0010976) | 2.50241587 |
| 42 | Recurrent bacterial skin infections (HP:0005406) | 2.50190685 |
| 43 | Truncus arteriosus (HP:0001660) | 2.49451715 |
| 44 | Oral leukoplakia (HP:0002745) | 2.47801779 |
| 45 | Meningitis (HP:0001287) | 2.47357615 |
| 46 | Hepatocellular necrosis (HP:0001404) | 2.45825197 |
| 47 | Agnosia (HP:0010524) | 2.44460445 |
| 48 | Pallor (HP:0000980) | 2.44237730 |
| 49 | Hepatosplenomegaly (HP:0001433) | 2.43759719 |
| 50 | Agammaglobulinemia (HP:0004432) | 2.43267044 |
| 51 | IgG deficiency (HP:0004315) | 2.42824827 |
| 52 | Cutaneous photosensitivity (HP:0000992) | 2.42441852 |
| 53 | Abnormality of T cells (HP:0002843) | 2.41522358 |
| 54 | Granulocytopenia (HP:0001913) | 2.41018984 |
| 55 | Increased IgE level (HP:0003212) | 2.40187877 |
| 56 | Pancytopenia (HP:0001876) | 2.40073313 |
| 57 | Bone marrow hypocellularity (HP:0005528) | 2.38625366 |
| 58 | Optic neuritis (HP:0100653) | 2.37794568 |
| 59 | Retrobulbar optic neuritis (HP:0100654) | 2.37794568 |
| 60 | Abnormality of T cell physiology (HP:0011840) | 2.37155066 |
| 61 | Abnormality of the nasal mucosa (HP:0000433) | 2.35210840 |
| 62 | Lymphoma (HP:0002665) | 2.34874722 |
| 63 | Increased IgM level (HP:0003496) | 2.34785396 |
| 64 | Orchitis (HP:0100796) | 2.33129668 |
| 65 | Optic nerve coloboma (HP:0000588) | 2.31845884 |
| 66 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.31790437 |
| 67 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.31790437 |
| 68 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.30719976 |
| 69 | Urticaria (HP:0001025) | 2.30716275 |
| 70 | Abnormality of DNA repair (HP:0003254) | 2.30213206 |
| 71 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.29198293 |
| 72 | Encephalitis (HP:0002383) | 2.28580852 |
| 73 | Basal cell carcinoma (HP:0002671) | 2.28562002 |
| 74 | Seborrheic dermatitis (HP:0001051) | 2.27751818 |
| 75 | Abnormality of the preputium (HP:0100587) | 2.27085465 |
| 76 | Deep palmar crease (HP:0006191) | 2.24277461 |
| 77 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.24212770 |
| 78 | Selective tooth agenesis (HP:0001592) | 2.24203914 |
| 79 | Lymphopenia (HP:0001888) | 2.23476581 |
| 80 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.22245688 |
| 81 | Combined immunodeficiency (HP:0005387) | 2.21538915 |
| 82 | Clubbing of toes (HP:0100760) | 2.20168646 |
| 83 | Amaurosis fugax (HP:0100576) | 2.19348943 |
| 84 | Recurrent sinusitis (HP:0011108) | 2.15386994 |
| 85 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.14599831 |
| 86 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.14435317 |
| 87 | Severe combined immunodeficiency (HP:0004430) | 2.13444608 |
| 88 | Vacuolated lymphocytes (HP:0001922) | 2.12206905 |
| 89 | Abnormality of chromosome stability (HP:0003220) | 2.12055025 |
| 90 | Breast hypoplasia (HP:0003187) | 2.11770526 |
| 91 | Cellular immunodeficiency (HP:0005374) | 2.10997433 |
| 92 | Recurrent skin infections (HP:0001581) | 2.10644272 |
| 93 | 11 pairs of ribs (HP:0000878) | 2.10276963 |
| 94 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.09647823 |
| 95 | Leukopenia (HP:0001882) | 2.09614417 |
| 96 | Hypochromic anemia (HP:0001931) | 2.08415240 |
| 97 | Abnormality of iron homeostasis (HP:0011031) | 2.07592520 |
| 98 | Mediastinal lymphadenopathy (HP:0100721) | 2.06216689 |
| 99 | Meckel diverticulum (HP:0002245) | 2.05716307 |
| 100 | Pustule (HP:0200039) | 2.05637803 |
| 101 | Abnormality of the ileum (HP:0001549) | 2.05539494 |
| 102 | Stomach cancer (HP:0012126) | 2.04743111 |
| 103 | Abnormality of the fingertips (HP:0001211) | 2.04731705 |
| 104 | Patellar aplasia (HP:0006443) | 2.04399622 |
| 105 | Poikiloderma (HP:0001029) | 2.03993949 |
| 106 | Multiple enchondromatosis (HP:0005701) | 2.03355531 |
| 107 | Rough bone trabeculation (HP:0100670) | 2.03200938 |
| 108 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.01706700 |
| 109 | Prolonged bleeding time (HP:0003010) | 2.00999711 |
| 110 | Cellulitis (HP:0100658) | 2.00829522 |
| 111 | Hyperthyroidism (HP:0000836) | 2.00536340 |
| 112 | Severe visual impairment (HP:0001141) | 1.98870177 |
| 113 | Thoracic kyphosis (HP:0002942) | 1.98867938 |
| 114 | Neoplasm of the adrenal cortex (HP:0100641) | 1.98437599 |
| 115 | Abnormality of glycolipid metabolism (HP:0010969) | 1.98433580 |
| 116 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.98433580 |
| 117 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.98433580 |
| 118 | T lymphocytopenia (HP:0005403) | 1.97853864 |
| 119 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.97707073 |
| 120 | Inflammation of the large intestine (HP:0002037) | 1.97588541 |
| 121 | Macrocytic anemia (HP:0001972) | 1.97307388 |
| 122 | Myopathic facies (HP:0002058) | 1.97090331 |
| 123 | Mitochondrial inheritance (HP:0001427) | 1.97014117 |
| 124 | Reduced antithrombin III activity (HP:0001976) | 1.95494379 |
| 125 | Chest pain (HP:0100749) | 1.95235916 |
| 126 | Colitis (HP:0002583) | 1.94998122 |
| 127 | Premature graying of hair (HP:0002216) | 1.94840994 |
| 128 | Chronic obstructive pulmonary disease (HP:0006510) | 1.94621298 |
| 129 | Obstructive lung disease (HP:0006536) | 1.94621298 |
| 130 | Retinal atrophy (HP:0001105) | 1.94592383 |
| 131 | Gastrointestinal inflammation (HP:0004386) | 1.94567033 |
| 132 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.93396731 |
| 133 | Ectopic kidney (HP:0000086) | 1.92035534 |
| 134 | Eczematoid dermatitis (HP:0000976) | 1.91858466 |
| 135 | Abnormality of T cell number (HP:0011839) | 1.91093146 |
| 136 | Horseshoe kidney (HP:0000085) | 1.91081357 |
| 137 | Increased CSF lactate (HP:0002490) | 1.90653846 |
| 138 | Acute necrotizing encephalopathy (HP:0006965) | 1.90605728 |
| 139 | Microretrognathia (HP:0000308) | 1.89842841 |
| 140 | Sepsis (HP:0100806) | 1.88992326 |
| 141 | Abnormality of the prostate (HP:0008775) | 1.88936212 |
| 142 | Eosinophilia (HP:0001880) | 1.88751170 |
| 143 | Loss of speech (HP:0002371) | 1.87420621 |
| 144 | Neutropenia (HP:0001875) | 1.87300914 |
| 145 | Abnormality of the renal collecting system (HP:0004742) | 1.86627771 |
| 146 | Anomalous pulmonary venous return (HP:0010772) | 1.86610044 |
| 147 | Tented upper lip vermilion (HP:0010804) | 1.86177383 |
| 148 | Abnormal spermatogenesis (HP:0008669) | 1.85563596 |
| 149 | Gastrointestinal stroma tumor (HP:0100723) | 1.85239817 |
| 150 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.85205219 |
| 151 | Epistaxis (HP:0000421) | 1.84702580 |
| 152 | Abnormality of eosinophils (HP:0001879) | 1.84362225 |
| 153 | Premature loss of primary teeth (HP:0006323) | 1.84139407 |
| 154 | Respiratory difficulties (HP:0002880) | 1.83951433 |
| 155 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.83320913 |
| 156 | Purpura (HP:0000979) | 1.82358270 |
| 157 | Gastrointestinal infarctions (HP:0005244) | 1.81392514 |
| 158 | Polycythemia (HP:0001901) | 1.80570248 |
| 159 | Broad distal phalanx of finger (HP:0009836) | 1.80262073 |
| 160 | Hepatic necrosis (HP:0002605) | 1.79106361 |
| 161 | Cerebral palsy (HP:0100021) | 1.76251354 |
| 162 | Progressive muscle weakness (HP:0003323) | 1.75554001 |
| 163 | Progressive external ophthalmoplegia (HP:0000590) | 1.73416146 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 4.57171795 |
| 2 | WEE1 | 3.31662929 |
| 3 | MAP3K11 | 3.09720179 |
| 4 | MAP4K1 | 3.02034752 |
| 5 | RIPK4 | 2.66412295 |
| 6 | NEK2 | 2.63302973 |
| 7 | EEF2K | 2.47847441 |
| 8 | STK16 | 2.18475254 |
| 9 | EIF2AK1 | 2.07718555 |
| 10 | CDK19 | 2.03305848 |
| 11 | TSSK6 | 1.99238150 |
| 12 | TNK2 | 1.95495954 |
| 13 | PRPF4B | 1.91506034 |
| 14 | STK10 | 1.90918614 |
| 15 | PDK2 | 1.89866570 |
| 16 | CDC7 | 1.83929448 |
| 17 | SMG1 | 1.74093968 |
| 18 | BTK | 1.73101793 |
| 19 | TRIB3 | 1.72191499 |
| 20 | IRAK4 | 1.66108995 |
| 21 | TXK | 1.64057575 |
| 22 | RPS6KB2 | 1.64055792 |
| 23 | BRSK2 | 1.54041141 |
| 24 | TBK1 | 1.53578012 |
| 25 | SRPK1 | 1.52854511 |
| 26 | KIT | 1.52259006 |
| 27 | NME2 | 1.50802789 |
| 28 | ZAP70 | 1.50514726 |
| 29 | IKBKE | 1.50109687 |
| 30 | ATR | 1.49707335 |
| 31 | TEC | 1.48241182 |
| 32 | PLK1 | 1.44211981 |
| 33 | TYK2 | 1.43805190 |
| 34 | TTK | 1.42103285 |
| 35 | TLK1 | 1.41410979 |
| 36 | MAP3K10 | 1.40669974 |
| 37 | MAP2K3 | 1.40511171 |
| 38 | BLK | 1.40009363 |
| 39 | BCKDK | 1.36202701 |
| 40 | VRK2 | 1.35222500 |
| 41 | VRK1 | 1.34509891 |
| 42 | GRK6 | 1.31963634 |
| 43 | CDK7 | 1.31781672 |
| 44 | EIF2AK3 | 1.29462333 |
| 45 | PASK | 1.27443378 |
| 46 | CCNB1 | 1.27376770 |
| 47 | CSF1R | 1.26263235 |
| 48 | CDK4 | 1.25864536 |
| 49 | BRSK1 | 1.24141141 |
| 50 | CLK1 | 1.23984478 |
| 51 | TAOK2 | 1.23335290 |
| 52 | TESK1 | 1.22503325 |
| 53 | MARK2 | 1.21519450 |
| 54 | NME1 | 1.20309311 |
| 55 | STK4 | 1.18070035 |
| 56 | AURKB | 1.17354088 |
| 57 | ARAF | 1.17279613 |
| 58 | FLT3 | 1.17036564 |
| 59 | DYRK3 | 1.16255135 |
| 60 | RPS6KA4 | 1.16131422 |
| 61 | FES | 1.15672892 |
| 62 | IKBKB | 1.14828501 |
| 63 | MAP3K8 | 1.12100341 |
| 64 | TAOK1 | 1.11767024 |
| 65 | RAF1 | 1.08614855 |
| 66 | PLK4 | 1.07785975 |
| 67 | IRAK3 | 1.06983795 |
| 68 | PIM2 | 1.06940803 |
| 69 | PIM1 | 1.05211737 |
| 70 | ZAK | 1.04605298 |
| 71 | SIK2 | 1.04233953 |
| 72 | BRAF | 1.03930786 |
| 73 | SYK | 0.99794184 |
| 74 | JAK3 | 0.98229167 |
| 75 | ICK | 0.97063436 |
| 76 | BMX | 0.91506392 |
| 77 | NEK1 | 0.90228444 |
| 78 | SIK1 | 0.89989001 |
| 79 | ITK | 0.88687465 |
| 80 | PAK4 | 0.88428030 |
| 81 | FGR | 0.88289672 |
| 82 | CDK12 | 0.87993569 |
| 83 | MAPKAPK3 | 0.87683717 |
| 84 | MATK | 0.87560869 |
| 85 | ACVR1B | 0.86203672 |
| 86 | CHEK2 | 0.85929666 |
| 87 | LYN | 0.84518936 |
| 88 | TGFBR1 | 0.82861625 |
| 89 | MAP3K1 | 0.79602214 |
| 90 | CHEK1 | 0.78968029 |
| 91 | LRRK2 | 0.78328654 |
| 92 | TNIK | 0.75893273 |
| 93 | MAP2K6 | 0.73687797 |
| 94 | TAOK3 | 0.72034430 |
| 95 | AURKA | 0.71985779 |
| 96 | DMPK | 0.71519236 |
| 97 | PAK1 | 0.71517541 |
| 98 | MKNK1 | 0.71066830 |
| 99 | NLK | 0.70922731 |
| 100 | DYRK2 | 0.70733553 |
| 101 | LCK | 0.70561658 |
| 102 | EIF2AK2 | 0.69954540 |
| 103 | ERN1 | 0.68216301 |
| 104 | MAP2K2 | 0.66838654 |
| 105 | EPHA2 | 0.66475190 |
| 106 | TESK2 | 0.65821826 |
| 107 | MAP3K14 | 0.65638624 |
| 108 | KDR | 0.63326049 |
| 109 | MARK3 | 0.62439273 |
| 110 | MAP4K2 | 0.58047606 |
| 111 | MAPK12 | 0.56873266 |
| 112 | HCK | 0.55785199 |
| 113 | JAK2 | 0.55169462 |
| 114 | RPS6KL1 | 0.55105518 |
| 115 | RPS6KC1 | 0.55105518 |
| 116 | CHUK | 0.54425275 |
| 117 | ABL2 | 0.53959551 |
| 118 | RPS6KA6 | 0.53239670 |
| 119 | PLK3 | 0.53158343 |
| 120 | MKNK2 | 0.52172133 |
| 121 | PTK6 | 0.50671326 |
| 122 | MAPK11 | 0.50176525 |
| 123 | PDPK1 | 0.50137112 |
| 124 | CSK | 0.48693963 |
| 125 | YES1 | 0.47608995 |
| 126 | SCYL2 | 0.47192816 |
| 127 | MAPKAPK2 | 0.45948894 |
| 128 | ATM | 0.44088405 |
| 129 | CSNK1G3 | 0.44079138 |
| 130 | CSNK2A1 | 0.43875737 |
| 131 | RPS6KA1 | 0.43308945 |
| 132 | RPS6KA5 | 0.43113554 |
| 133 | CDK2 | 0.43029995 |
| 134 | RPS6KB1 | 0.41699096 |
| 135 | EPHB1 | 0.41386221 |
| 136 | PDK1 | 0.41293029 |
| 137 | MAP3K3 | 0.40914603 |
| 138 | MAP3K6 | 0.40369796 |
| 139 | PRKCQ | 0.40322518 |
| 140 | ILK | 0.39763595 |
| 141 | ALK | 0.39002632 |
| 142 | SIK3 | 0.38731602 |
| 143 | CSNK1A1L | 0.37675828 |
| 144 | PRKD2 | 0.36028206 |
| 145 | FGFR4 | 0.34286628 |
| 146 | PRKCI | 0.31066796 |
| 147 | DYRK1B | 0.30647807 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 4.24747872 |
| 2 | Mismatch repair_Homo sapiens_hsa03430 | 3.67229362 |
| 3 | Base excision repair_Homo sapiens_hsa03410 | 3.35408581 |
| 4 | Ribosome_Homo sapiens_hsa03010 | 3.32280992 |
| 5 | Spliceosome_Homo sapiens_hsa03040 | 2.85100961 |
| 6 | Homologous recombination_Homo sapiens_hsa03440 | 2.78642936 |
| 7 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.52678268 |
| 8 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.50251915 |
| 9 | Proteasome_Homo sapiens_hsa03050 | 2.41857679 |
| 10 | RNA polymerase_Homo sapiens_hsa03020 | 2.38606676 |
| 11 | RNA transport_Homo sapiens_hsa03013 | 2.26990149 |
| 12 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.21596138 |
| 13 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.14122695 |
| 14 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.10256428 |
| 15 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.07604017 |
| 16 | Cell cycle_Homo sapiens_hsa04110 | 2.07204389 |
| 17 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.05556341 |
| 18 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.00790214 |
| 19 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.00202506 |
| 20 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.63909027 |
| 21 | Parkinsons disease_Homo sapiens_hsa05012 | 1.52241756 |
| 22 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.50155810 |
| 23 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.46713215 |
| 24 | Measles_Homo sapiens_hsa05162 | 1.46696186 |
| 25 | RNA degradation_Homo sapiens_hsa03018 | 1.44535989 |
| 26 | Basal transcription factors_Homo sapiens_hsa03022 | 1.43044854 |
| 27 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.42866075 |
| 28 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.38233689 |
| 29 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.37121207 |
| 30 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.36690585 |
| 31 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.28257236 |
| 32 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.25720163 |
| 33 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.22658178 |
| 34 | Purine metabolism_Homo sapiens_hsa00230 | 1.21638613 |
| 35 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.18654213 |
| 36 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.14554491 |
| 37 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.13558261 |
| 38 | Salmonella infection_Homo sapiens_hsa05132 | 1.12223588 |
| 39 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.10662050 |
| 40 | Lysosome_Homo sapiens_hsa04142 | 1.09278991 |
| 41 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.05575075 |
| 42 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.03306082 |
| 43 | Phagosome_Homo sapiens_hsa04145 | 1.02128237 |
| 44 | Influenza A_Homo sapiens_hsa05164 | 1.01609677 |
| 45 | Leishmaniasis_Homo sapiens_hsa05140 | 1.01035344 |
| 46 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.98694187 |
| 47 | Legionellosis_Homo sapiens_hsa05134 | 0.95953291 |
| 48 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.95794044 |
| 49 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.95334934 |
| 50 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.93800462 |
| 51 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.91383495 |
| 52 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.86684919 |
| 53 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.86114018 |
| 54 | Huntingtons disease_Homo sapiens_hsa05016 | 0.85378825 |
| 55 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.85230638 |
| 56 | Other glycan degradation_Homo sapiens_hsa00511 | 0.82821442 |
| 57 | Malaria_Homo sapiens_hsa05144 | 0.81904339 |
| 58 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.81327429 |
| 59 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.80765028 |
| 60 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.79622450 |
| 61 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.79306172 |
| 62 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.79267695 |
| 63 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.78344375 |
| 64 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.76673401 |
| 65 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.76261463 |
| 66 | Allograft rejection_Homo sapiens_hsa05330 | 0.76107979 |
| 67 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.75934638 |
| 68 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.75608032 |
| 69 | HTLV-I infection_Homo sapiens_hsa05166 | 0.74454287 |
| 70 | Apoptosis_Homo sapiens_hsa04210 | 0.73484136 |
| 71 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.73026320 |
| 72 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.72802359 |
| 73 | Sulfur relay system_Homo sapiens_hsa04122 | 0.72133716 |
| 74 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.70787309 |
| 75 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.70315148 |
| 76 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.68734115 |
| 77 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.67762505 |
| 78 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.67135265 |
| 79 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.65106409 |
| 80 | Hepatitis B_Homo sapiens_hsa05161 | 0.64746239 |
| 81 | Shigellosis_Homo sapiens_hsa05131 | 0.64712004 |
| 82 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.61491852 |
| 83 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.61025396 |
| 84 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.59895351 |
| 85 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.59760633 |
| 86 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.59161534 |
| 87 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.58865402 |
| 88 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.57255522 |
| 89 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.55667797 |
| 90 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.55333617 |
| 91 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.54720673 |
| 92 | Alzheimers disease_Homo sapiens_hsa05010 | 0.52750144 |
| 93 | Endocytosis_Homo sapiens_hsa04144 | 0.51527168 |
| 94 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.51304448 |
| 95 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.50718760 |
| 96 | Bladder cancer_Homo sapiens_hsa05219 | 0.50330494 |
| 97 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.50207233 |
| 98 | Galactose metabolism_Homo sapiens_hsa00052 | 0.49349241 |
| 99 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.48596365 |
| 100 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.47409242 |
| 101 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.47384963 |
| 102 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.45804364 |
| 103 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.44641817 |
| 104 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.43875513 |
| 105 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.42929525 |
| 106 | Hepatitis C_Homo sapiens_hsa05160 | 0.39952608 |
| 107 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.39721203 |
| 108 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.39589869 |
| 109 | Asthma_Homo sapiens_hsa05310 | 0.36960224 |
| 110 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.35757021 |
| 111 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.35347834 |
| 112 | Thyroid cancer_Homo sapiens_hsa05216 | 0.35224874 |
| 113 | Tuberculosis_Homo sapiens_hsa05152 | 0.35138917 |
| 114 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.33510387 |
| 115 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.33466480 |
| 116 | Carbon metabolism_Homo sapiens_hsa01200 | 0.30152001 |
| 117 | Viral myocarditis_Homo sapiens_hsa05416 | 0.26444908 |
| 118 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.26073579 |
| 119 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.25212032 |
| 120 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.24673108 |
| 121 | Colorectal cancer_Homo sapiens_hsa05210 | 0.23993338 |
| 122 | ABC transporters_Homo sapiens_hsa02010 | 0.23050050 |
| 123 | Pertussis_Homo sapiens_hsa05133 | 0.22845240 |
| 124 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.22790447 |
| 125 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.21112709 |
| 126 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.20836798 |

